UMEM Educational Pearls

Title: The 65 Trial

Category: Critical Care

Keywords: Hypotension, Shock, Mean Arterial Pressure, Vasopressors, Elderly Patients, Geriatrics (PubMed Search)

Posted: 7/15/2025 by Mark Sutherland, MD
Click here to contact Mark Sutherland, MD

Following up Dr. Flint's pearl from the other day, the largest study to date looking at a lower Mean Arterial Pressure (MAP) target in elderly ICU patients is the “65” Trial, published in JAMA in 2020.  This trial compared a MAP target of 60-65 to the usual goal of >65, in critically ill patients age 65 and older.  It included 2,455 patients in 65 ICUs in the UK, and found no difference between the groups.  

Bottom Line: Although most intensivists still target a MAP > 65 regardless of patient age, you do have some evidence to support you if you want to target 60-65 in patients over age sixty-five.  However, there are some important limitations (well outlined in the PulmCrit article linked below), and therapy should always be optimized to the patient and markers of end organ perfusion.

References

Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network

PulmCrit - The 65 trial: Is 60 the new 65?